Welcome to our dedicated page for SelectQuote news (Ticker: SLQT), a resource for investors and traders seeking the latest updates and insights on SelectQuote stock.
SelectQuote, Inc. (symbol: SLQT) is a leading Direct-to-Consumer (DTC) distribution platform that enables consumers to shop for health, life, auto, and home insurance policies online. Founded over 25 years ago, SelectQuote revolutionized the process of buying term life insurance by providing unbiased price comparisons from highly-rated term life insurance companies. Today, SelectQuote stands as America’s #1 term life sales agency, renowned for its customer-centric approach and innovative technology.
The company functions through three primary lines: SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home. These segments are further categorized into four reportable segments: Senior, Healthcare Services, Life, and Auto & Home.
SelectQuote's business model revolves around generating revenues through commissions earned by selling insurance products on behalf of its carrier partners. The trusted companies represented by SelectQuote have been carefully chosen based on their ability to offer favorable rates, especially for individuals with certain risk factors such as smoking or existing health conditions like high cholesterol or blood pressure.
One of the standout features of SelectQuote is its dedicated personal agents who are committed to answering all customer questions, providing comprehensive information for informed decision-making, and diligently shopping for the best prices available. The company’s breakthrough technology has streamlined what is often a lengthy and involved application process, ensuring a hassle-free experience for consumers.
Recent achievements include expanding their Senior and Healthcare Services segments to better cater to an aging population and those seeking specialized healthcare plans. Current projects focus on leveraging technology to enhance customer experience, expand product offerings, and increase market penetration.
Financially, SelectQuote continues to show strong performance, driven by a combination of strategic partnerships and innovative service offerings. The company's commitment to customer satisfaction and operational efficiency positions it well for future growth.
SelectQuote (NYSE: SLQT) reported Q1 FY2025 results with revenue of $292.3 million, up from $232.7 million in Q1 FY2024. The company posted a net loss of $44.5 million, compared to a $31.1 million loss in the prior year period. Segment highlights include Senior Revenue of $92.9 million, Healthcare Services Revenue of $155.7 million with 86,521 SelectRx members (64% growth), and Life Revenue of $39.3 million.
For FY2025, SelectQuote expects revenue between $1.425-$1.525 billion, net income/loss range of $(59) million to $3 million, and Adjusted EBITDA of $100-130 million.
SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a growing Healthcare Services platform, has announced the release of its fiscal first quarter 2025 financial results. The results will be made public before market open on Monday, November 4, 2024.
Following the release, CEO Tim Danker and CFO Ryan Clement will host a conference call at 8:30 am ET on the same day to discuss the results. Interested parties can register for the call using the provided link. The event will also be webcasted live via the company's investor relations website.
SelectQuote, Inc. (NYSE: SLQT) has completed a $100 million securitization transaction on October 15, 2024. This transaction provides advanced financing against expected collections for previously sold policies. The company's receivables totaled approximately $1 billion as of June 30, 2024, with only a portion securitized in this deal.
The proceeds will be used to pay down a portion of outstanding term debt. The new securitized debt offers a lower cost of capital than the current term debt. The transaction also includes a maturity extension for the remaining term debt from September 15, 2025 to September 30, 2027, with a potential further extension to September 30, 2028.
SelectQuote has hired an investment bank to conduct a strategic review of all available options to meet payment milestones, strengthen the balance sheet, and fund continued investment in core business lines.
SelectQuote (NYSE: SLQT) reported Q4 FY2024 results with revenue of $307.2 million, up from $221.8 million in Q4 FY2023. The company posted a net loss of $31.0 million, improved from a $47.8 million loss last year. Adjusted EBITDA was $14.4 million, compared to -$5.8 million in Q4 FY2023.
For full FY2024, revenue reached $1.3 billion, up from $1.0 billion in FY2023. Net loss narrowed to $34.1 million from $58.5 million. Adjusted EBITDA grew to $117.0 million from $74.3 million.
The company provided FY2025 guidance, projecting revenue of $1.4-$1.5 billion, net loss of $42-$6 million, and Adjusted EBITDA of $90-$120 million. SelectQuote also announced plans for a $100 million commissions receivable securitization to optimize its balance sheet.
SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, has announced the release of its fiscal fourth quarter and full year 2024 financial results. The results will be disclosed before market open on Friday, September 13, 2024. Following the release, CEO Tim Danker and CFO Ryan Clement will host a conference call at 8:30 am ET on the same day to discuss the results.
Interested parties can register for the conference call using the provided link. The event will also be webcasted live via SelectQuote's investor relations website. This announcement provides investors and analysts with an opportunity to gain insights into the company's financial performance and future outlook.
SelectQuote (NYSE: SLQT) announced that its full-service medication management pharmacy, SelectRx, will open a third fulfillment facility in Olathe, Kansas, to support its rapid growth. The new 54,000 square foot state-of-the-art facility is expected to open in the first half of 2025, significantly expanding the pharmacy's capacity. SelectQuote plans to add over 50 new positions at the location, including pharmacists, pharmacy fulfillment technicians, and various support roles.
Since its launch in 2021, SelectRx has grown its membership from under 5,000 to over 75,000 members who receive regular prescription shipments in adherence-friendly packaging. In 2023, SelectRx was recognized as a Patient-Centered Pharmacy Home (PCPH) by The Compliance Team, emphasizing health maintenance, preventative screening, and medication management for chronically-ill patients.
SelectQuote, Inc. reported a strong third quarter of fiscal year 2024 with consolidated revenue of $376.4 million, net income of $8.6 million, and Adjusted EBITDA of $46.6 million. The company raised its Fiscal Year 2024 guidance ranges for revenue, net loss, and Adjusted EBITDA. The Senior segment showed impressive results with revenue of $204.3 million and Adjusted EBITDA of $61.5 million. The Healthcare Services segment saw revenue of $124.2 million and an Adjusted EBITDA of $1.6 million, with significant growth in SelectRx members. Life segment revenue was $40.7 million, while the Auto & Home segment revenue reached $9.1 million. CEO Tim Danker expressed confidence in the company's performance and outlook for shareholder value.
SelectQuote, Inc. (NYSE: SLQT) announced the release date of its fiscal third quarter 2024 financial results and the presentation at RBC's Global Healthcare Conference. The earnings call will be held on May 9, 2024, at 9:00 am ET, hosted by CEO Tim Danker and CFO Ryan Clement. The company will also participate in a fireside chat at the conference on May 15, 2024.
FAQ
What is the current stock price of SelectQuote (SLQT)?
What is the market cap of SelectQuote (SLQT)?
What does SelectQuote, Inc. do?
How does SelectQuote generate revenue?
What are the main segments of SelectQuote?
What is unique about SelectQuote's service?
Who are the trusted companies represented by SelectQuote?
How has SelectQuote revolutionized the insurance buying process?
What recent achievements has SelectQuote made?
How does SelectQuote support its customers?
What is the role of technology in SelectQuote's operations?
What are SelectQuote's future growth prospects?
